Evidence map›Paper›PMID 31691919›Full record

ArticleJournal of computer-aided molecular design2019

Comparison of affinity ranking using AutoDock-GPU and MM-GBSA scores for BACE-1 inhibitors in the D3R Grand Challenge 4.

Léa El Khoury, Diogo Santos-Martins, Sukanya Sasmal, Jérôme Eberhardt, Giulia Bianco, Francesca Alessandra Ambrosio, Leonardo Solis-Vasquez, Andreas Koch, Stefano Forli, David L Mobley

Abstract read
In one paragraph

Article in Journal of computer-aided molecular design, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. FromACS omega · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Synthesis and Docking Studies of Glycolipids Inspired byMolecules (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. Pharmacophore-based virtual screening andFrontiers in pharmacology · 2025
    Article
  10. Article
  11. Exploring the Antibiofilm Effect of Sertraline in Synergy withPharmaceuticals (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Nature-Inspired 1-Phenylpyrrolo[2,1-Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  14. Article
  15. Computational identification ofFrontiers in pharmacology · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Novel Allosteric Effectors Targeting Human Transcription Factor TEAD.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Léa El KhouryDepartment of Pharmaceutical Sciences, University of California, Irvine, Irvine, USA.ORCID 0000-0003-3157-9425
Diogo Santos-MartinsDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA, 92037-1000, USA.ORCID 0000-0003-4622-3747
Sukanya SasmalDepartment of Pharmaceutical Sciences, University of California, Irvine, Irvine, USA.ORCID 0000-0003-2731-5777
Jérôme EberhardtDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA, 92037-1000, USA.
Giulia BiancoDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA, 92037-1000, USA.
Francesca Alessandra AmbrosioDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA, 92037-1000, USA.
Leonardo Solis-VasquezEmbedded Systems and Applications Group, Technische Universität Darmstadt, Darmstadt, Germany.
Andreas KochEmbedded Systems and Applications Group, Technische Universität Darmstadt, Darmstadt, Germany.ORCID 0000-0002-1164-3082
Stefano ForliDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA, 92037-1000, USA. forli@scripps.edu.ORCID 0000-0002-5964-7111
David L MobleyDepartment of Pharmaceutical Sciences, University of California, Irvine, Irvine, USA. dmobley@mobleylab.org.ORCID 0000-0002-1083-5533

Funding

X-ray Crystallographic Fragment Screening CoreU54GM103368 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SARAFIANOS, STEFAN G, TORBETT, BRUCE EDWARD · 2017 to 2018
$11.1M
AutoDock Suite: Next Generation Environment for Drug DesignR01GM069832 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI FORLI, STEFANO · 2004 to 2025
$10.9M
Computational alchemy for molecular design and optimizationR01GM108889 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI MOBLEY, DAVID LOWELL · 2014 to 2022
$2.5M
Advancing predictive physical modeling through focused development of model systems to drive new modeling innovationsR01GM124270 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI MOBLEY, DAVID LOWELL · 2018 to 2021
$1.5M
NIGMS NIH HHS R01 GM069832NIGMS NIH HHS R01 GM108889NIGMS NIH HHS R01 GM124270NIGMS NIH HHS U54 GM103368NIH HHS U54- GM103368
6 · The paper itself

Abstract

Molecular docking has been successfully used in computer-aided molecular design projects for the identification of ligand poses within protein binding sites. However, relying on docking scores to rank different ligands with respect to their experimental affinities might not be sufficient. It is believed that the binding scores calculated using molecular mechanics combined with the Poisson-Boltzman surface area (MM-PBSA) or generalized Born surface area (MM-GBSA) can predict binding affinities more accurately. In this perspective, we decided to take part in Stage 2 of the Drug Design Data Resource (D3R) Grand Challenge 4 (GC4) to compare the performance of a quick scoring function, AutoDock4, to that of MM-GBSA in predicting the binding affinities of a set of [Formula: see text]-Amyloid Cleaving Enzyme 1 (BACE-1) ligands. Our results show that re-scoring docking poses using MM-GBSA did not improve the correlation with experimental affinities. We further did a retrospective analysis of the results and found that our MM-GBSA protocol is sensitive to details in the protein-ligand system: (i) neutral ligands are more adapted to MM-GBSA calculations than charged ligands, (ii) predicted binding affinities depend on the initial conformation of the BACE-1 receptor, (iii) protonating the aspartyl dyad of BACE-1 correctly results in more accurate binding affinity predictions.

Indexed as

Drug DesignAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesBinding SitesHumansLigandsMolecular Docking SimulationProtein BindingSurface PropertiesAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesBACE1 protein, humanLigandsAutoDockDockingMM-GBSAScoring functions

Identifiers

PMID31691919
PMCPMC7027993

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.